Match!
Journal of The European Academy of Dermatology and Venereology
IF
5.11
Papers
12170
Papers 10000
1 page of 1,000 pages (10k results)
Newest
Since the beginning of the pandemic of Coronavirus disease (COVID-19) an increasing number of skin manifestations have been reported.(1,2) Most reports concern adult patients and describe various patterns of skin eruptions, in most of cases with low specificity and no univocal temporal association with the onset of systemic symptoms of COVID-19.(1-3).
Source
As a novel coronavirus pathogen, COVID-19 and the current associated pandemic has rapidly transformed daily life since its first detection in December 2019 in Wuhan, China. Not only are strict social distancing measures now the status quo, but within the occupational setting of healthcare provision, healthcare workers (HCWs) have had to quickly adapt to an entirely different way of working. Part of this new routine encompasses the now habitual donning of personal protective equipment (PPE), not ...
Source
#1Hyun Jeong Ju (Catholic University of Korea)H-Index: 2
#2Jin‐woo Kwon (Catholic University of Korea)
Last. Jung Min Bae (Catholic University of Korea)H-Index: 15
view all 4 authors...
Seasonality is clinically indicated in several chronic skin diseases;[1] however, the epidemiologic data supporting these indications are often lacking. Such information would therefore be of great interest to clinicians due to its significant implications to public health. In this study, we conducted a nationwide, population-based, cross-sectional study to examine the seasonality of common chronic skin diseases, including atopic dermatitis (AD), psoriasis, vitiligo, and alopecia areata (AA).
Source
#1Alvise Sernicola (Sapienza University of Rome)
#2Giorgia Carnicelli (Sapienza University of Rome)
Last. T. Grieco (Sapienza University of Rome)H-Index: 5
view all 8 authors...
Since the new fatal pneumonia was identified in December 2019 in Wuhan, China, the WHO declared the infection a health emergency of international concern. The novel ss-RNA ss-coronavirus (SARS-CoV-2) spreads through airborne and direct contagion; virulence is high in the elderly and in patients with diabetes, chronic pulmonary, cardiovascular and neoplastic diseases. SARS-CoV-2 ssRNA is recognized by intracellular Pattern Recognition Receptors (PRRs), which trigger NF-kB - the master regulator o...
Source
#1Erin McMeniman (UQ: University of Queensland)H-Index: 7
#2Aideen McInerny-Leo (UQ: University of Queensland)H-Index: 19
Last. Richard A. Sturm (UQ: University of Queensland)H-Index: 51
view all 10 authors...
1-5% of individuals with melanoma have a strong family history(1) with a causal gene identified in ~30% of those families, most commonly CDKN2A.(2) Genetic testing and counselling for CDKN2A improves sun-protective and surveillance behaviour(3) without negative psychological sequelae.(4) Given these advantages, dermatologists need to recognise those with a sufficient a priori risk to warrant the offer of genetic testing.
Source
#2Ali Zinebi (Sidi Mohamed Ben Abdellah University)
Last. Jalal Elbenaye (Sidi Mohamed Ben Abdellah University)
view all 3 authors...
Since CoronaVirus Disease 19 (COVID-19) was declared as a pandemic, all medical specialties were at the front, including dermatology. Daily, there are observations mentioning possible cutaneous manifestations of Sars-Cov-2. Among these manifestations, the most often was a rash which could be erythematous, morbilliform or urticarial mimicking viral exanthema, or chickenpox-like vesicles [1-3]. Anecdotally, dengue-like petechial eruption was reported [4].
Source
#1Catherine Gunawan (University of Pelita Harapan)
#2Angela (University of Pelita Harapan)
view all 3 authors...
We have read with great interest the articles regarding cutaneous manifestations in Coronavirus Disease 2019 (COVID-19) infection. Studies showed 20.4% of COVID-19 patients developed cutaneous manifestations and might be the only presenting symptom.(1) To date, previous cases reported urticaria as one of the cutaneous manifestations in COVID-19.(2)(1)(3)(4) This atypical symptom might lead to misdiagnosis, delayed diagnosis, and virus transmission, especially in countries where cutaneous manifes...
Source
#1Cristina Mugheddu (University of Cagliari)H-Index: 3
#2Laura Pizzatti (University of Cagliari)
Last. Franco Rongioletti (University of Cagliari)H-Index: 30
view all 5 authors...
Novel coronavirus 2019 (SARS-CoV2) pandemic has particularly affected Italy, with a profound impact on the therapeutic strategy for complex disorder such as psoriasis, whose extensive skin damage might expose to an increased infective risk compared to the general population. Psoriasis treatment relies on immunosuppression, and although most experts agree that the benefit-to risk-ratio is in favor of maintaining selective biologic therapies, and small molecules such as apremilast, they recommend ...
Source
#1Tina Lejding (Lund University)H-Index: 1
#2Cecilia Svedman (Lund University)H-Index: 21
Last. Magnus Bruze (Lund University)H-Index: 50
view all 3 authors...
We want to present a patient referred to our Department for investigation of contact allergy as possible explanation for widespread skin lesions. The patient is a 49 year old man. He has hiatus hernia and takes Omeprazole on daily basis. He also has arthrosis in his knees and sometimes takes painkillers. In the past he used to have localized psoriatic skin lesions. He has no anamnesis of atopy. The patients' mother has rhinoconjuntivitis and his father has psoriasis. No known heredity for other ...
Source
#1Rodney Sinclair (University of Melbourne)H-Index: 37
#2Lara Trindade de Carvalho (Wellington Management Company)
Last. Nekma MeahH-Index: 1
view all 4 authors...
Low-dose oral minoxidil (0.25mg daily) has been successfully used in combination with spironolactone in the treatment of female pattern hair loss (FPHL)(1) . Oral minoxidil (5mg daily) has been shown to be efficacious in male pattern hair loss (MPHL)(2,3) . The objective of our study was to evaluate the efficacy and safety of low-dose sublingual minoxidil (0.45mg daily) in MPHL and FPHL. Sublingual administration bypasses hepatic metabolism, thereby increasing bioavailability compared with oral ...
Source
12345678910
Top fields of study
Surgery
Pathology
Dermatology
Disease
Psoriasis
Medicine